Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma

The estimated number of patients with hepatocellular carcinoma selected for liver transplantation using expanded selection criteria

(2009) Christian Toso et al.   TRANSPLANT INTERNATIONAL

Liver Transplantation for Hepatocellular Carcinoma: Beyond the Milan Criteria

(2008) F. Y. Yao   AMERICAN JOURNAL OF TRANSPLANTATION

Delayed Introduction of Reduced-Dose Tacrolimus, and Renal Function in Liver Transplantation: The ‘ReSpECT' Study

(2008) J. M. Neuberger et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors

(2008) Marco Vivarelli et al.   ANNALS OF SURGERY

Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma

(2008) Z. Wang et al.   CLINICAL CANCER RESEARCH

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients database

(2008) Christian Toso et al.   HEPATOLOGY

Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma

(2008) Anne-Christine Piguet et al.   JOURNAL OF HEPATOLOGY

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

(2008) Vincenzo Mazzaferro et al.   LANCET ONCOLOGY

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma

(2008) Michael A. Zimmerman et al.   LIVER TRANSPLANTATION

Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma

(2008) Christian Toso et al.   LIVER TRANSPLANTATION

Sirolimus-Based Immunosuppression Therapy in Liver Transplantation for Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria

(2008) J. Zhou et al.   TRANSPLANTATION PROCEEDINGS